Visceral Leishmaniasis
Infectious Disease
Visceral Leishmaniasis is treated with 1 medication in our database, including IMPAVIDO. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Profounda. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Visceral Leishmaniasis treatment below.
What help exists for Visceral Leishmaniasis
4
drugs indexed
2
with copay cards
2
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Visceral Leishmaniasis
4 totalAmBisome
amphotericin B · Gilead Sciences
🎟💙Amphotericin B
Amphotericin B · Xellia
IMPAVIDO
miltefosine · Profounda
🎟💙Amphotericin B liposome
Amphotericin B liposome · Gilead Sciences
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Visceral Leishmaniasis drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |